Literature DB >> 12827048

Outcomes of repeat penetrating keratoplasty and risk factors for graft failure.

Daniel J Weisbrod1, Marisa Sit, Joel Naor, Allan R Slomovic.   

Abstract

PURPOSE: To compare repeat penetrating keratoplasty (PKP) with primary PKP with respect to patient characteristics, survival rates, and risk factors for graft failure.
METHODS: Retrospective, consecutive, noncomparative case series of 116 patients who underwent repeat PKP and who were identified from a cohort of 696 PKPs performed by one surgeon over a 7.5-year period.
RESULTS: Compared with patients who underwent primary PKP, regraft patients were 5 years older, had a higher rate of peripheral anterior synechiae (PAS), were more likely to require intraocular pressure (IOP)-lowering medications prior to surgery, were more likely to develop postoperative corneal neovascularization, were less likely to be phakic, and were more likely to undergo PKP in conjunction with a lens procedure. There was no difference between the two groups with respect to the distribution of original diagnoses leading to PKP and the rate of graft rejection. Two- and 5-year survival rates for repeat PKP were 63.9% and 45.6%, respectively. In a multivariate analysis, the original diagnosis leading to corneal transplantation, the presence of preoperative PAS, intraoperative anterior vitrectomy, and postoperative corneal neovascularization were identified as risk factors for graft failure in patients undergoing a regraft.
CONCLUSIONS: Patients undergoing PKP for the first and second time share common risk factors for graft failure, namely, the original diagnosis leading to corneal transplantation, the presence of preoperative PAS, and the occurrence of postoperative corneal neovascularization. The difference in graft survival rates between the two groups can be partially explained on the basis of higher rates of the latter two risk factors among regrafts.

Entities:  

Mesh:

Year:  2003        PMID: 12827048     DOI: 10.1097/00003226-200307000-00008

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  24 in total

1.  Comparison of outcomes of penetrating keratoplasty versus Descemet's stripping automated endothelial keratoplasty for penetrating keratoplasty graft failure due to corneal edema.

Authors:  Anna S Kitzmann; George R Wandling; John E Sutphin; Kenneth M Goins; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2012-01-22       Impact factor: 2.031

2.  Penetrating keratoplasty: outcomes from a corneal unit compared to national data.

Authors:  P Beckingsale; I Mavrikakis; N Al-Yousuf; E Mavrikakis; S M Daya
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

3.  Repeat penetrating keratoplasty: indications, graft survival, and visual outcome.

Authors:  H Al-Mezaine; M D Wagoner
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  Twelve-year follow-up of penetrating keratoplasty.

Authors:  Takashi Ono; Sosuke Ishiyama; Takeshi Hayashidera; Yosai Mori; Ryohei Nejima; Kazunori Miyata; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2016-11-24       Impact factor: 2.447

5.  A retrospective clinical study of Xinjiang Uygur patients with corneal allograft rejection.

Authors:  Reziwan Maimaitiming; Xin Yang; Kelala Wupuer; Nan Ye; Na Kong; Baoyu Gu; Yuanyuan Fan; Lan Shao; Zhiqiang Pan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone.

Authors:  Yang Kyung Cho; Hironori Uehara; Jason R Young; Puneet Tyagi; Uday B Kompella; Xiaohui Zhang; Ling Luo; Nirbhai Singh; Bonnie Archer; Balamurali K Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-30       Impact factor: 4.799

7.  Ocular surface rehabilitation: Application of human amniotic membrane in high-risk penetrating keratoplasties.

Authors:  Pho Nguyen; Kelly Rue; Martin Heur; Samuel C Yiu
Journal:  Saudi J Ophthalmol       Date:  2014-07-02

8.  Vascular endothelial growth factor receptor 1 morpholino decreases angiogenesis in a murine corneal suture model.

Authors:  Yang Kyung Cho; Hironori Uehara; Jason R Young; Bonnie Archer; Xiaohui Zhang; Balamurali K Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

Review 9.  Indications, surgical procedures and outcomes of keratoplasty at a Tertiary University-based hospital: a review of 10 years' experience.

Authors:  Eman M Al-Sharif; Majed Alkharashi
Journal:  Int Ophthalmol       Date:  2021-02-24       Impact factor: 2.031

10.  Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.

Authors:  Yang Kyung Cho; Xiaohui Zhang; Hironori Uehara; Jason R Young; Bonnie Archer; Balamurali Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.